Sung-Hwan Cho
Director Ejecutivo en CHOA PHARMACEUTICAL CO., LTD. .
Fortuna: 2 M $ al 30/04/2024
Perfil
Sung-Hwan Cho is currently the Vice Chairman & Co-Chief Executive Officer at ChoA Pharmaceutical Co., Ltd.
and the President & Chief Executive Officer at Medipharm.
He has an undergraduate degree from Korea University and a graduate degree from Chung-Ang University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/03/2023 | 1 849 162 ( 5.97% ) | 2 M $ | 30/04/2024 |
Cargos activos de Sung-Hwan Cho
Empresas | Cargo | Inicio |
---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Director Ejecutivo | - |
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Director Ejecutivo | - |
Formación de Sung-Hwan Cho.
Korea University | Undergraduate Degree |
Chung-Ang University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Bolsa de valores
- Insiders
- Sung-Hwan Cho